In a report released today, Roger Song from Jefferies maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target of $28.00. The company’s shares closed yesterday at ...

Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Kura Oncology in a research report issued to ...

Shares of Kura Sushi have dropped more than 20% so far in 2025 after the company completed a secondary offering to build up cash for new store expansion. Kura Sushi USA faces inflation challenges ...

Kura Oncology (NASDAQ:KURA – Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.63) EPS for the quarter, beating analysts’ consensus ...

Lake Street analyst Mark Smith maintained a Hold rating on Kura Sushi USA (KRUS – Research Report) today and set a price target of $103.00. The company’s shares closed yesterday at $102.18.

After hours: February 3 at 5:43:47 PM EST Loading Chart for KURA ...

Kura Oncology, Inc. is a San Diego based clinical-stage biopharmaceutical concern focused on the development of precision medicines for the treatment of cancer. The company is advancing three ...